newsfilter
← Latest News
Business Wire·

Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit

CAMBRIDGE, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and Guardant Health, Inc. announced an agreement to settle false advertising challenges that the companies had filed against each other under the Lanham Act related to advertising for their respective liquid genomic profiling assays. Under the terms of the settlement, the lawsuit and counterclaims will be dismissed with prejudice. The companies also agreed to create a rapid-resolution process in the event of further advertising-related disputes.